Medical abortion care encompasses the management of various clinical conditions including spontaneous and induced abortion (both viable and non-viable pregnancies), incomplete abortion and intrauterine fetal demise, as well as post-abortion contraception. Medical management of abortion generally involves...
DESCRIPTION: The Joint Task Force on Practice Parameters, which comprises representatives of the American Academy of Allergy, Asthma and Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI), formed a workgroup to review evidence and provide guidance to health care provide...
Hormones corticosurrénaliennes,
Antihistaminiques,
Antagonistes des leucotriènes,
Administration par voie nasale,
Administration par voie orale,
Facteurs âges,
Association de médicaments,
Antihistaminiques/usage thérapeutique,
Antagonistes des leucotriènes/usage thérapeutique,
Rhinite allergique saisonnière,
Hormones corticosurrénaliennes/administration et posologie,
Hormones corticosurrénaliennes/usage thérapeutique,
Rhinite allergique saisonnière/diagnostic,
Rhinite allergique saisonnière/traitement médicamenteux
Jones, N. L;
Koletzko, S;
Goodman, K;
Bontems, P;
Cadranel, S;
Casswall, T;
Czinn, S;
Gold, B. D;
Guarner, J;
Elitsur, Y;
Homan, M;
Kalach, N;
Kori, M;
Madrazo, A;
Megraud, F;
Papadopoulou, A;
Rowland, M.
BACKGROUND: Because of the changing epidemiology of Helicobacter pylori infection and low efficacy of currently recommended therapies, an update of the European Society for Paediatric Gastroenterology Hepatology and Nutrition/North American Society for Pediatric Gastroenterology, Hepatology and Nutrition...
DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on oral pharmacologic treatment of type 2 diabetes in adults. This guideline serves as an update to the 2012 ACP guideline on the same topic. This guideline is endor...
Ofrecer recomendaciones basadas en la evidencia para la prevención, detección, tratamiento y seguimiento de las queratosis actínicas, con el fin de apoyar al personal de salud en los diferentes niveles de atención, buscando garantizar una atención integral, homogénea, con calidad, equidad y eficien...
Leucémie lymphoïde/diagnostic,
Leucémie lymphoïde/thérapie,
Leucémie myéloïde/diagnostic,
Leucémie myéloïde/thérapie,
Analyse cytogénétique/méthodes,
Vincristine/usage thérapeutique,
Doxorubicine/usage thérapeutique,
Dexaméthasone/usage thérapeutique,
Mésilate d'imatinib/usage thérapeutique,
Dasatinib/usage thérapeutique,
Anticorps monoclonaux/usage thérapeutique,
Association de médicaments,
Transplantation homologue
Gisbert, JP;
Molina-Infante, J;
Amador, J;
Bermejo, F;
Bujanda, L;
Calvet, X;
Castro-Fernández, M;
Cuadrado-Lavín, A;
Elizalde, JI;
Gene, E;
Gomollón, F;
Lanas, Á;
Martín de Argila, C;
Mearin, F;
Montoro, M;
Pérez-Aisa, Á;
Pérez-Trallero, E;
McNicholl, AG.
Helicobacter pylori approximately infect 50% of Spanish population and causes chronic gastritis, peptic ulcer and gastric cancer. Until now, three consensus meetings on H.pylori infection had been performed in Spain (the last in 2012). The changes in the treatment schemes, and the increasing available ev...
Antibactériens/usage thérapeutique,
Inhibiteurs de la pompe à protons/usage thérapeutique,
Bismuth/usage thérapeutique,
Algorithmes,
Méthode Delphi,
Association de médicaments,
Gastrite/complications,
Infections à Helicobacter,
Helicobacter pylori,
Probiotiques,
Inhibiteurs de la pompe à protons,
Récidive,
Thérapie de rattrapage,
Tumeurs de l'estomac,
Ulcère gastrique,
Échec thérapeutique,
Gastrite/traitement médicamenteux,
Infections à Helicobacter/traitement médicamenteux,
Helicobacter pylori/effets des médicaments et des substances chimiques
Macle, L;
Cairns, J;
Leblanc, K;
Tsang, T;
Skanes, A;
Cox, JL;
Healey, JS;
Bell, A;
Pilote, L;
Andrade, JG;
Mitchell, LB;
Atzema, C;
Gladstone, D;
Sharma, M;
Verma, S;
Connolly, S;
Dorian, P;
Parkash, R;
Talajic, M;
Nattel, S;
Verma, A.
The Canadian Cardiovascular Society (CCS) Atrial Fibrillation (AF) Guidelines Committee provides periodic reviews of new data to produce focused updates that address clinically important advances in AF management. This 2016 Focused Update deals with: (1) the management of antithrombotic therapy for AF pa...
Anticoagulants,
Cardiotoniques,
Antiagrégants plaquettaires,
Digoxine,
Magnésium,
Syndrome coronarien aigu/thérapie,
Algorithmes,
Anticoagulants/usage thérapeutique,
Auricule de l'atrium/chirurgie,
Fibrillation auriculaire,
Entraînement électrosystolique,
Cardiotoniques/effets indésirables,
Ablation par cathéter,
Cardiotoniques/administration et posologie,
Fibrillation auriculaire/thérapie,
Fibrillation auriculaire/complications,
Hémorragie/induit chimiquement,
Hémorragie/prévention et contrôle,
Magnésium/usage thérapeutique,
Intervention coronarienne percutanée,
Antiagrégants plaquettaires/usage thérapeutique,
Complications postopératoires/prévention et contrôle,
Infarctus du myocarde avec sus-décalage du segment ST/thérapie,
Accident vasculaire cérébral/prévention et contrôle,
Maladie des artères coronaires/complications,
Digoxine/administration et posologie,
Digoxine/effets indésirables,
Association de médicaments,
Inhibiteurs du facteur Xa/usage thérapeutique,
Fibrinolytiques/usage thérapeutique,
Inhibiteurs du facteur Xa
Singh, J. A;
Saag, K. G;
Bridges Junior, S. L;
Akl, E. A;
Bannuru, R. R;
Sullivan, M. C;
Vaysbrot, E;
McNaughton, C;
Osani, M;
Shmerling, R. H;
Curtis, J. R;
Furst, D. E;
Parks, D;
Kavanaugh, A;
O'Dell, J;
King, C;
Leong, A;
Matteson, E. L;
Schousboe, J. T;
Drevlow, B;
Ginsberg, S;
Grober, J;
St Clair, E. W;
Tindall, E;
Miller, A. S;
McAlindon, T.
OBJECTIVE: To develop a new evidence-based, pharmacologic treatment guideline for rheumatoid arthritis (RA). METHODS: We conducted systematic reviews to synthesize the evidence for the benefits and harms of various treatment options. We used the Grading of Recommendations Assessment, Development and Eval...
Rationale for the guidelines: Since the publication of the WHO Guidelines for the management of sexually transmitted infections in 2003, changes in the epidemiology of STIs and advancements in prevention, diagnosis and treatment necessitate changes in STI management. These guidelines provide updated trea...
Rationale for the guidelines: Since the publication of the WHO Guidelines for the management of sexually transmitted infections in 2003, changes in the epidemiology of STIs and advancements in prevention, diagnosis and treatment necessitate changes in STI management. There is an urgent need to update tre...
Neisseria gonorrhoeae,
Gonorrhée/traitement médicamenteux,
Résistance microbienne aux médicaments,
Céfixime/administration et posologie,
Spectinomycine/administration et posologie,
Ceftriaxone/administration et posologie,
Gentamicine/administration et posologie,
Kanamycine/administration et posologie,
Tétracycline/administration et posologie,
Érythromycine/administration et posologie,
Povidone iodée/administration et posologie,
Nitrate d'argent/administration et posologie,
Chloramphénicol/usage thérapeutique,
Antibactériens/administration et posologie,
Association de médicaments
